XOMAO
XOMA Corporation
NASDAQ · Healthcare · Biotechnology · US
$25.00
+0.00%Latest reported
- Last report date
- May 12, 2026
- EPS actual
- $0.18
- EPS estimate
- $0.17
- Revenue actual
- $12.3M
- Revenue estimate
- $13.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +721.0%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 30, 2026